Therapeutic approches of &beta;-Thalassemia

Alatrash Yehya A.; Buruiana Sanda

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

245

SM ISO690:2012

ALATRASH, Yehya A., BURUIANA, Sanda. Therapeutic approches of β-Thalassemia. In: The European Journal of Biomedical and Life Sciences, 2020, nr. 4, pp. 3-5. ISSN 2310-5674.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

The European Journal of Biomedical and Life Sciences

Numărul 4 / 2020 / ISSN 2310-5674

Therapeutic approches of β-Thalassemia

Pag. 3-5

Alatrash Yehya A., Buruiana Sanda

”Nicolae Testemițanu” State University of Medicine and Pharmacy

Disponibil în IBN: 20 iunie 2021

Rezumat

β-thalassemia is an inherited disorder of haemoglobin associated with ineffective erythropoiesis and anemia. During the last 40 years, in addition to the considerable progress made in prevention and treatment of thalassemias, there have also been major advances in their symptomatic management, at least in wealthier countries where appropriate facilities are available. Therapeutic management depends on the severity of the disease.

Cuvinte-cheie
Thalassemia, treatment, erythropoiesis

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Alatrash, Y.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Buruiana, S.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='en'>Therapeutic approches of &beta;-Thalassemia</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2020</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>2310-5674</relatedIdentifier>
<subjects>
<subject>Thalassemia</subject>
<subject>treatment</subject>
<subject>erythropoiesis</subject>
</subjects>
<dates>
<date dateType='Issued'>2020-12-11</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='en' descriptionType='Abstract'><p>&beta;-thalassemia is an inherited disorder of haemoglobin associated with ineffective erythropoiesis and anemia. During the last 40 years, in addition to the considerable progress made in prevention and treatment of thalassemias, there have also been major advances in their symptomatic management, at least in wealthier countries where appropriate facilities are available. Therapeutic management depends on the severity of the disease.</p></description>
</descriptions>
<formats>
<format>uri</format>
</formats>
</resource>